Home / AGYTF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AGYTF make money? Does AGYTF have pricing power? What's the Earnings Whisper? Will AGYTF profit more as the business scales? What is AGYTF's management track record? Is AGYTF's current price justified?

Allergy Therapeutics plc

$0.15 +$0.04 (+36.36%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.15

Day Range

$0.15 - $0.15

Year Range

$0.09$0.15

Market Cap

756.3M

AVG Volume

7.07K

Trailing/Forward PE

-4.8/12.06

PEG ratio

0.02

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (GBP)

AGYTF Revenue (GBP) by quarter
Period	Revenue (GBP)
26 Q2	36.27M
25 Q4	30.48M
25 Q2	34.03M
24 Q4	21.63M
24 Q2	33.57M
23 Q4	19.69M
23 Q2	39.9M
22 Q4	24.07M
22 Q2	48.7M
21 Q4	30.3M

Net Income (GBP)

AGYTF Net Income (GBP) by quarter
Period	Net Income (GBP)
26 Q2	-19.91M
25 Q4	-29M
25 Q2	-11.09M
24 Q4	-24.57M
24 Q2	-15.65M
23 Q4	-34.56M
23 Q2	-8.51M
22 Q4	-20.45M
22 Q2	6.67M
21 Q4	-12.05M

Operating Income (GBP)

AGYTF Operating Income (GBP) by quarter
Period	Operating Income (GBP)
26 Q2	-11.92M
25 Q4	-14M
25 Q2	-8.61M
24 Q4	-23.37M
24 Q2	-11.89M
23 Q4	-27.95M
23 Q2	-7.96M
22 Q4	-20.15M
22 Q2	7.17M
21 Q4	-8.84M

EBITDA (GBP)

AGYTF EBITDA (GBP) by quarter
Period	EBITDA (GBP)
26 Q2	-9.76M
25 Q4	-27M
25 Q2	-4.15M
24 Q4	-22.81M
24 Q2	-9.35M
23 Q4	-11.71M
23 Q2	-5.43M
22 Q4	-8.13M
22 Q2	6.11M
21 Q4	-3.83M

Cash Flows (GBP)

AGYTF Cash Flows (GBP) by quarter
Period	Cash Flows (GBP)
26 Q2	-14.51M
25 Q4	-23M
25 Q2	-9.23M
24 Q4	-22.9M
24 Q2	-12.64M
23 Q4	-25.13M
23 Q2	-9.71M
22 Q4	-19.55M
22 Q2	2.56M
21 Q4	-6.17M

EPS (GBP)

AGYTF EPS (GBP) by quarter
Period	EPS (GBP)
26 Q2	-0
25 Q4	-0.01
25 Q2	-0
24 Q4	-0.01
24 Q2	-0.01
23 Q4	-0.03
23 Q2	-0.01
22 Q4	-0.03
22 Q2	0.01
21 Q4	-0.01

Expenses (GBP)

AGYTF Expenses (GBP) by quarter
Period	Expenses (GBP)
26 Q2	34.05M
25 Q4	23.45M
25 Q2	28.84M
24 Q4	34.07M
24 Q2	34.61M
23 Q4	37.19M
23 Q2	35.85M
22 Q4	35.66M
22 Q2	29.89M
21 Q4	30.68M

Cash & Debt (GBP)

AGYTF Cash & Debt (GBP) by quarter
Period	Cash & Debt (GBP)
26 Q2	10.08M
25 Q4	17.56M
25 Q2	21.68M
24 Q4	12.71M
24 Q2	13.52M
23 Q4	14.85M
23 Q2	15.2M
22 Q4	20.52M
22 Q2	41.38M
21 Q4	40.27M

Debt ratios

AGYTF Debt ratios by quarter
Period	Debt ratios
26 Q2	-0.26
25 Q4	-0.67
25 Q2	-0.48
24 Q4	-0.37
24 Q2	0.11
23 Q4	-1.13
23 Q2	0.48
22 Q4	-2.45
22 Q2	-3.06
21 Q4	-2.33

Margins

AGYTF Margins by quarter
Period	Margins
26 Q2	53.26%
25 Q4	32.83%
25 Q2	61.3%
24 Q4	42.62%
24 Q2	61.12%
23 Q4	37.91%
23 Q2	64.62%
22 Q4	56.48%
22 Q2	73.74%
21 Q4	65.95%

Return on Capital

AGYTF Return on Capital by quarter
Period	Return on Capital
26 Q2	-468.69%
25 Q4	74.93%
25 Q2	155.03%
24 Q4	-662.31%
24 Q2	-59.15%
23 Q4	722.66%
23 Q2	-22.41%
22 Q4	-53.25%
22 Q2	12.13%
21 Q4	-24.83%

Shares Outstanding

AGYTF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	5.22B
25 Q4	4.77B
25 Q2	4.77B
24 Q4	4.77B
24 Q2	2.72B
23 Q4	1.48B
23 Q2	1.44B
22 Q4	1.29B
22 Q2	1.39B
21 Q4	1.39B

Book Value Per Share (GBP)

AGYTF Book Value Per Share (GBP) by quarter
Period	Book Value Per Share (GBP)
26 Q2	0
25 Q4	-0.01
25 Q2	-0
24 Q4	0
24 Q2	0.01
23 Q4	-0
23 Q2	0.03
22 Q4	0.03
22 Q2	0.04
21 Q4	0.03

Total Assets (GBP)

AGYTF Total Assets (GBP) by quarter
Period	Total Assets (GBP)
26 Q2	71M
25 Q4	67.54M
25 Q2	72.97M
24 Q4	64.83M
24 Q2	69.08M
23 Q4	68.4M
23 Q2	71.61M
22 Q4	73.58M
22 Q2	91.97M
21 Q4	88.09M

PE Ratio

AGYTF PE Ratio by quarter
Period	PE Ratio
Sep 22	233.04
Sep 22	221.57
Sep 22	242.71
Sep 22	244.04
Aug 22	239.45
Aug 22	237.64
Aug 22	231.62
Aug 22	232.91
Jul 22	230.82
Jul 22	234.18
Jul 22	236.86
Jul 22	233.61
Jul 22	232.31
Jun 22	216.4
Jun 22	241.09
Jun 22	259.56
Jun 22	230.52
May 22	227.92
May 22	230.32
May 22	234.92
May 22	233.47
Apr 22	246.79
Apr 22	241.68
Apr 22	237.27
Apr 22	277.89
Apr 22	276.22
Mar 22	36.99
Mar 22	37.03
Mar 22	30.55
Mar 22	30.07
Feb 22	29.68
Feb 22	35.69
Feb 22	45.48
Feb 22	45.6
Jan 22	46.02
Jan 22	45.52
Jan 22	45.1
Jan 22	45.38
Dec 21	45.58
Dec 21	45.99
Dec 21	54.01
Dec 21	53.89
Dec 21	54.02
Nov 21	53.61
Nov 21	53.18
Nov 21	50.69
Nov 21	56
Oct 21	52.18
Oct 21	50.74
Oct 21	47.33
Oct 21	47.36
Oct 21	47.61
Sep 21	30.09
Sep 21	29.97
Sep 21	29.75
Sep 21	27.71
Aug 21	27.91
Aug 21	28.53
Aug 21	28.03
Aug 21	28.01
Jul 21	30.25
Jul 21	16.63
Jul 21	15.28
Jul 21	15.13
Jul 21	15.2
Jun 21	15.15
Jun 21	15.24
Jun 21	14.9
Jun 21	0.12
May 21	0.12
May 21	0.12
May 21	0.12
May 21	0.12
Apr 21	0.13
Apr 21	0.13
Apr 21	0.13
Apr 21	0.13
Apr 21	0.13
Mar 21	31.47
Mar 21	33.21
Mar 21	33.07
Mar 21	21.88
Feb 21	22.68
Feb 21	22.54
Feb 21	22.78
Feb 21	22.98
Jan 21	23.04
Jan 21	23.07
Jan 21	25.17
Jan 21	24.25
Dec 20	9.63
Dec 20	24.28
Dec 20	17.02
Dec 20	17.4
Dec 20	17.13
Nov 20	17.78
Nov 20	0.02
Nov 20	0.02
Nov 20	0.02
Oct 20	0.02

Free Cash Flow Yield

AGYTF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-12.03%
Sep 26	-12.01%
Aug 26	-12.03%
Aug 26	-12.13%
Aug 26	-12.03%
Aug 26	-11.99%
Jul 26	-11.98%
Jul 26	-11.84%
Jul 26	-11.96%
Jul 26	-11.91%
Jul 26	-11.86%
Jun 26	-12.57%
Jun 26	-13.55%
Jun 26	-13.75%
Jun 26	-13.68%
May 26	-16.31%
May 26	-16.28%
May 26	-16.15%
May 26	-16.52%
May 26	-16.45%
Apr 26	-16.4%
Apr 26	-16.38%
Apr 26	-16.31%
Apr 26	-16.02%
Mar 26	-17.14%
Mar 26	-17.25%
Mar 26	-17.06%
Mar 26	-17.34%
Feb 26	-17.43%
Feb 26	-17.42%
Feb 26	-17.65%
Feb 26	-17.6%
Jan 26	-17.69%
Jan 26	-17.64%
Jan 26	-17.29%
Jan 26	-17.33%
Jan 26	-17.4%
Dec 25	-17.45%
Dec 25	-17.29%
Dec 25	-17.28%
Dec 25	-17.23%
Nov 25	-17.11%
Nov 25	-16.93%
Nov 25	-17.03%
Nov 25	-17.02%
Oct 25	-16.94%
Oct 25	-17.2%
Oct 25	-21.21%
Oct 25	-22.34%
Oct 25	-22.54%
Sep 25	-23.12%
Sep 25	-23.25%
Sep 25	-23.41%
Sep 25	-23.3%
Aug 25	-23.3%
Aug 25	-23.32%
Aug 25	-23.38%
Aug 25	-23.21%
Aug 25	-22.9%
Jul 25	-23.18%
Jul 25	-23.16%
Jul 25	-23.27%
Jul 25	-23.56%
Jun 25	-23.66%
Jun 25	-23.2%
Jun 25	-23.42%
Jun 25	-23.34%
May 25	-23.21%
May 25	-23.36%
May 25	-22.91%
May 25	-22.95%
May 25	-22.89%
Apr 25	-22.97%
Apr 25	-23.72%
Apr 25	-23.4%
Apr 25	-18.9%
Mar 25	-36.7%
Mar 25	-36.66%
Mar 25	-36.73%
Mar 25	-36.68%
Feb 25	-35.71%
Feb 25	-35.85%
Feb 25	-35.74%
Feb 25	-35.21%
Jan 25	-35.18%
Jan 25	-35.44%
Jan 25	-34.55%
Jan 25	-34.66%
Jan 25	-35.27%
Dec 24	-35.72%
Dec 24	-35.66%
Dec 24	-35.83%
Dec 24	-36.18%
Nov 24	-36.16%
Nov 24	-35.58%
Nov 24	-35.83%
Nov 24	-31.79%
Nov 24	-31.79%
Oct 24	-31.89%
Oct 24	-32.11%

Price to Sales

AGYTF Price to Sales by quarter
Period	Price to Sales
Sep 26	4.73
Sep 26	4.74
Aug 26	4.73
Aug 26	4.69
Aug 26	4.73
Aug 26	4.75
Jul 26	4.75
Jul 26	4.81
Jul 26	4.76
Jul 26	4.78
Jul 26	4.8
Jun 26	4.53
Jun 26	4.2
Jun 26	4.14
Jun 26	4.16
May 26	3.49
May 26	3.5
May 26	3.52
May 26	3.44
May 26	3.46
Apr 26	3.47
Apr 26	3.47
Apr 26	3.49
Apr 26	3.55
Mar 26	3.3
Mar 26	3.28
Mar 26	3.32
Mar 26	3.27
Feb 26	3.25
Feb 26	3.25
Feb 26	3.21
Feb 26	3.22
Jan 26	3.2
Jan 26	3.21
Jan 26	3.27
Jan 26	3.27
Jan 26	3.25
Dec 25	3.24
Dec 25	3.27
Dec 25	3.28
Dec 25	3.29
Nov 25	3.31
Nov 25	3.34
Nov 25	3.32
Nov 25	3.33
Oct 25	3.34
Oct 25	3.29
Oct 25	2.67
Oct 25	2.53
Oct 25	2.51
Sep 25	2.78
Sep 25	2.76
Sep 25	2.74
Sep 25	2.75
Aug 25	2.75
Aug 25	2.75
Aug 25	2.74
Aug 25	2.77
Aug 25	2.8
Jul 25	2.77
Jul 25	2.77
Jul 25	2.76
Jul 25	2.72
Jun 25	2.71
Jun 25	2.77
Jun 25	2.74
Jun 25	2.75
May 25	2.76
May 25	2.75
May 25	2.8
May 25	2.8
May 25	2.8
Apr 25	2.79
Apr 25	2.71
Apr 25	2.74
Apr 25	3.39
Mar 25	1.67
Mar 25	1.67
Mar 25	1.67
Mar 25	1.67
Feb 25	1.72
Feb 25	1.71
Feb 25	1.72
Feb 25	1.74
Jan 25	1.74
Jan 25	1.73
Jan 25	1.77
Jan 25	1.77
Jan 25	1.74
Dec 24	1.72
Dec 24	1.72
Dec 24	1.71
Dec 24	1.69
Nov 24	1.7
Nov 24	1.72
Nov 24	1.71
Nov 24	1.93
Nov 24	1.93
Oct 24	1.92
Oct 24	1.91

EV/EBITDA

AGYTF EV/EBITDA by quarter
Period	EV/EBITDA
Mar 23	38.65
Mar 23	38.84
Mar 23	39.33
Mar 23	39.29
Feb 23	39.65
Feb 23	39.3
Feb 23	39.24
Feb 23	39.26
Jan 23	38.11
Jan 23	38.09
Jan 23	38.65
Jan 23	39.12
Dec 22	17.68
Dec 22	38.49
Dec 22	38.17
Dec 22	37.78
Dec 22	37.16
Nov 22	37.84
Nov 22	38.51
Nov 22	45.5
Nov 22	65.08
Oct 22	63.69
Oct 22	65.58
Oct 22	66.28
Oct 22	66.81
Sep 22	66.35
Sep 22	27.26
Sep 22	25.77
Sep 22	28.52
Sep 22	28.69
Aug 22	28.09
Aug 22	27.86
Aug 22	27.07
Aug 22	27.24
Jul 22	26.97
Jul 22	27.41
Jul 22	27.76
Jul 22	27.33
Jul 22	27.16
Jun 22	25.09
Jun 22	28.31
Jun 22	30.71
Jun 22	26.93
May 22	26.59
May 22	26.91
May 22	27.5
May 22	27.31
Apr 22	29.05
Apr 22	28.38
Apr 22	27.81
Apr 22	33.09
Apr 22	32.88
Mar 22	27.09
Mar 22	27.12
Mar 22	21.96
Mar 22	21.59
Feb 22	21.28
Feb 22	26.06
Feb 22	33.84
Feb 22	33.93
Jan 22	34.27
Jan 22	33.87
Jan 22	33.54
Jan 22	33.76
Dec 21	33.92
Dec 21	34.25
Dec 21	40.63
Dec 21	40.53
Dec 21	40.63
Nov 21	40.3
Nov 21	39.97
Nov 21	37.99
Nov 21	42.2
Oct 21	39.17
Oct 21	38.03
Oct 21	35.31
Oct 21	35.34
Oct 21	35.54
Sep 21	37.71
Sep 21	37.54
Sep 21	37.24
Sep 21	34.46
Aug 21	34.73
Aug 21	35.57
Aug 21	34.89
Aug 21	34.87
Jul 21	37.92
Jul 21	19.38
Jul 21	17.54
Jul 21	17.33
Jul 21	17.43
Jun 21	17.37
Jun 21	17.48
Jun 21	17.02
Jun 21	-3.1
May 21	-3.1
May 21	-3.1
May 21	-3.1
May 21	-3.1
Apr 21	-3.09

Price/Operating Cashflow

AGYTF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 22	31.96
Sep 22	30.39
Sep 22	33.29
Sep 22	33.47
Aug 22	32.84
Aug 22	32.59
Aug 22	31.77
Aug 22	31.94
Jul 22	31.66
Jul 22	32.12
Jul 22	32.49
Jul 22	32.04
Jul 22	31.86
Jun 22	29.68
Jun 22	33.07
Jun 22	35.6
Jun 22	31.62
May 22	31.26
May 22	31.59
May 22	32.22
May 22	32.02
Apr 22	33.85
Apr 22	33.15
Apr 22	32.54
Apr 22	38.11
Apr 22	37.88
Mar 22	17.69
Mar 22	17.71
Mar 22	14.61
Mar 22	14.38
Feb 22	14.2
Feb 22	17.07
Feb 22	21.75
Feb 22	21.81
Jan 22	22.01
Jan 22	21.77
Jan 22	21.57
Jan 22	21.7
Dec 21	21.8
Dec 21	22
Dec 21	25.83
Dec 21	25.77
Dec 21	25.83
Nov 21	25.64
Nov 21	25.44
Nov 21	24.24
Nov 21	26.78
Oct 21	24.96
Oct 21	24.27
Oct 21	22.63
Oct 21	22.65
Oct 21	22.77
Sep 21	19.22
Sep 21	19.14
Sep 21	19
Sep 21	17.69
Aug 21	17.82
Aug 21	18.21
Aug 21	17.9
Aug 21	17.89
Jul 21	19.32
Jul 21	10.62
Jul 21	9.76
Jul 21	9.66
Jul 21	9.71
Jun 21	9.68
Jun 21	9.73
Jun 21	9.52
Jun 21	0.08
May 21	0.08
May 21	0.08
May 21	0.08
May 21	0.08
Apr 21	0.08
Apr 21	0.08
Apr 21	0.08
Apr 21	0.08
Apr 21	0.08
Mar 21	18.5
Mar 21	19.52
Mar 21	19.44
Mar 21	12.86
Feb 21	13.33
Feb 21	13.24
Feb 21	13.39
Feb 21	13.51
Jan 21	13.54
Jan 21	13.56
Jan 21	14.79
Jan 21	14.25
Dec 20	5.66
Dec 20	14.27
Dec 20	10
Dec 20	10.23
Dec 20	10.07
Nov 20	10.45
Nov 20	0.01
Nov 20	0.01
Nov 20	0.01
Oct 20	0.01

Price to Book

AGYTF Price to Book by quarter
Period	Price to Book
Sep 26	136.25
Sep 26	136.42
Aug 26	136.26
Aug 26	135.16
Aug 26	136.24
Aug 26	136.7
Jul 26	136.82
Jul 26	138.49
Jul 26	137.08
Jul 26	137.66
Jul 26	138.17
Jun 26	130.43
Jun 26	121
Jun 26	119.24
Jun 26	119.83
May 26	100.52
May 26	100.69
May 26	101.52
May 26	99.22
May 26	99.64
Apr 26	99.96
Apr 26	100.08
Apr 26	100.48
Apr 26	102.29
Mar 25	51.7
Mar 25	51.75
Mar 25	51.66
Mar 25	51.72
Feb 25	53.14
Feb 25	52.92
Feb 25	53.1
Feb 25	53.89
Jan 25	53.93
Jan 25	53.54
Jan 25	54.92
Jan 25	54.74
Jan 25	53.8
Dec 24	53.12
Dec 24	53.2
Dec 24	52.96
Dec 24	52.45
Nov 24	52.47
Nov 24	53.33
Nov 24	52.96
Nov 24	59.68
Nov 24	59.69
Oct 24	59.5
Oct 24	59.09
Oct 24	59.03
Oct 24	58.76
Sep 24	4.61
Sep 24	4.63
Sep 24	4.7
Sep 24	4.7
Aug 24	4.7
Aug 24	4.67
Aug 24	4.76
Aug 24	4.83
Aug 24	4.82
Jul 24	4.79
Jul 24	4.78
May 23	5.34
May 23	5.32
May 23	5.32
May 23	5.25
Apr 23	5.27
Apr 23	5.33
Apr 23	5.34
Apr 23	5.33
Mar 23	1.53
Mar 23	4.36
Mar 23	4.38
Mar 23	4.43
Mar 23	4.43
Feb 23	4.47
Feb 23	4.43
Feb 23	4.42
Feb 23	4.43
Jan 23	4.3
Jan 23	4.3
Jan 23	4.36
Jan 23	4.41
Dec 22	2.14
Dec 22	4.34
Dec 22	4.31
Dec 22	4.27
Dec 22	4.2
Nov 22	4.28
Nov 22	4.35
Nov 22	5.09
Nov 22	7.17
Oct 22	7.02
Oct 22	7.22
Oct 22	7.29
Oct 22	7.35
Sep 22	7.3
Sep 22	5.68
Sep 22	5.4
Sep 22	5.91
Sep 22	5.94

No video analysis for this stock yet. Request one from our team.

News: AGYTF

proactiveinvestors.com · 29 Jul 2026

Boston Scientific beats second quarter expectations, raises full-year outlook

Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while...

proactiveinvestors.com · 29 Jul 2026

Allergy Therapeutics reports accelerated revenue growth in its second half

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) told investors that revenue growth accelerated in its second half and has guided for a further...

proactiveinvestors.co.uk · 29 Jul 2026

Allergy Therapeutics reports accelerated revenue growth in its second half

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) told investors that revenue growth accelerated in its second half and has guided for a further step-up in the current year as Grassmuno enters its first full peak treatment season. Second-half revenue is expected to reach £23.6 million, up more than 12% on a reported basis from £21 million a year earlier.

proactiveinvestors.com · 28 Jul 2026

Allergy Therapeutics names Helge Weiner-Trapness as executive chair

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has appointed former HSBC banker Helge Weiner-Trapness as executive chairman as the biotechnology...

proactiveinvestors.co.uk · 28 Jul 2026

Allergy Therapeutics names Helge Weiner-Trapness as executive chair

Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has appointed former HSBC banker Helge Weiner-Trapness as executive chairman as the biotechnology group explores a potential dual primary listing in Hong Kong. Weiner-Trapness, who joined the group as chief strategy officer and an executive director in January 2026, brings more than 30 years of investment banking experience in the US and Asia.

AI Analysis

Allergy Therapeutics plc

Video analysis: AGYTF

News: AGYTF

Boston Scientific beats second quarter expectations, raises full-year outlook

Allergy Therapeutics reports accelerated revenue growth in its second half

Allergy Therapeutics reports accelerated revenue growth in its second half

Allergy Therapeutics names Helge Weiner-Trapness as executive chair

Allergy Therapeutics names Helge Weiner-Trapness as executive chair

Similar companies